Matthew L Posard
Director at HALO
Data refreshed: Oct 11, 2026, 11:42 PM UTC
Total filings
8
Buys
0
$0
Sells
8
$2.6M
Grants & other
0
$0
Recent filings
| Filed | Symbol | Type | Qty | Value |
|---|---|---|---|---|
| Oct 2, 2026 | HALO Halozyme Therapeutics, Inc. | SELL | 730 | $78K |
| Oct 2, 2026 | HALO Halozyme Therapeutics, Inc. | SELL | 3,300 | $358K |
| Oct 2, 2026 | HALO Halozyme Therapeutics, Inc. | SELL | 1,100 | $121K |
| Oct 2, 2026 | HALO Halozyme Therapeutics, Inc. | SELL | 100 | $11K |
| Sep 17, 2026 | HALO Halozyme Therapeutics, Inc. | SELL | 3,100 | $329K |
| Sep 17, 2026 | HALO Halozyme Therapeutics, Inc. | SELL | 3,000 | $320K |
| Sep 17, 2026 | HALO Halozyme Therapeutics, Inc. | SELL | 8,896 | $961K |
| Sep 17, 2026 | HALO Halozyme Therapeutics, Inc. | SELL | 4,000 | $436K |